LONDON — Britain’s state-funded health service is responsible for paying for an HIV-prevention drug that has been called a “game changer” in the fight against AIDS, a court ruled Tuesday. The health service said it would appeal, which means the drug — which advocates say can prevent infection in people at high risk of contracting
